Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide—a GLP-1 receptor agonist originally developed for type 2 diabetes—has become widely used for weight loss because it reduces hunger and slows stomach emptying. However, not every person is a safe candidate for this medication. Before starting semaglutide therapy through PlexusDx or any provider, you need to know which health conditions and medications create real contraindications.
Medical Conditions That Rule Out Semaglutide Use
Semaglutide carries absolute contraindications with certain serious health conditions. Personal or family history of medullary thyroid carcinoma (MTC)—a rare cancer of the thyroid—is a hard stop; animal studies showed GLP-1 agonists promote thyroid tumors in rodent models, though human risk remains unclear. Multiple endocrine neoplasia syndrome type 2 (MEN2) is similarly off-limits because it predisposes people to MTC. Pancreatitis—acute inflammation of the pancreas—must be fully resolved and its cause identified before considering semaglutide, since GLP-1 drugs may increase pancreatitis risk in susceptible individuals.
Severe gallbladder disease, uncontrolled severe depression or suicidal ideation, and advanced diabetic retinopathy also require careful evaluation or avoidance. Pregnancy and breastfeeding are contraindications; semaglutide may harm fetal development and passes into breast milk. Patients with a history of thyroid nodules or suspicious thyroid ultrasound findings should undergo endocrinology clearance before starting therapy. PlexusDx providers screen for these conditions during your initial consultation to keep you safe.
Medication Interactions and Drug Combinations to Avoid
Semaglutide slows gastric emptying, which can reduce how fast your body absorbs other oral medications. This matters most for drugs requiring rapid absorption—including certain birth control pills, antibiotics, and medications for heart rhythm issues. If you take insulin or insulin-releasing diabetes medications (like sulfonylureas), combining them with semaglutide increases hypoglycemia risk and requires dose adjustment by your doctor. Incretin-based therapies (DPP-4 inhibitors like sitagliptin) combined with semaglutide may cause excessive GLP-1 stimulation and aren't typically recommended together.
Blood pressure medications may need adjustment as semaglutide-induced weight loss can lower your baseline pressure. Always inform your PlexusDx provider of every prescription, over-the-counter medication, and supplement you take—including blood thinners, thyroid medications, and cholesterol drugs—so they can review interactions with your specific semaglutide dose.
Age, Kidney Function, and Metabolic Health Screening
Semaglutide hasn't been extensively studied in children under 12 years old, and its safety in adolescents requires careful provider judgment and family discussion. Adults over 65 can use semaglutide but may experience more pronounced side effects like nausea; dose escalation may proceed more slowly. Kidney disease changes how your body processes and eliminates semaglutide metabolites. While mild-to-moderate kidney impairment (eGFR above 30) doesn't strictly contraindicate semaglutide, severe renal failure requires specialist input and possible dose limitation.
Liver function also matters: patients with cirrhosis or decompensated liver disease should avoid semaglutide because limited data exist on safety in this population. PlexusDx requests baseline kidney and liver function labs (creatinine, eGFR, ALT, AST) as part of its screening process to ensure your organs can safely handle the medication and flag any need for dose adjustment or specialist consultation.
How Genetic Testing Refines Your Semaglutide Eligibility
Even if you pass basic medical screening, your genetic makeup influences how you'll respond to semaglutide and whether it's truly your best choice. PlexusDx Precision Peptide Genetic Test examines variants in key pathways—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—that predict which patients show the strongest weight loss response and lowest adverse event rates. These aren't pharmacogenomic tests; they map your peptide-pathway biology across 14 mechanisms, 49 peptides, and 150+ genetic insights unique to your metabolism.
Patients with specific genetic profiles may achieve better results with tirzepatide (a dual GIP/GLP-1 agonist) rather than semaglutide alone, or they may benefit from PlexusDx GLP-Squared (semaglutide plus tirzepatide combined). Adding the Precision Peptide Genetic Test after your first month of semaglutide treatment—just $99—lets your provider fine-tune therapy to your biology, avoiding months of trial-and-error dosing. This data-driven approach maximizes safety and efficacy beyond standard medical screening.
Getting Cleared: What to Expect in a PlexusDx Initial Consultation
PlexusDx begins every patient relationship with a detailed medical history questionnaire and review of your current medications, allergies, and past surgeries. You'll be asked directly about personal or family thyroid cancer, pancreatitis, gallstones, kidney disease, liver disease, depression, and suicidal thoughts. A licensed healthcare provider—not an algorithm—evaluates your responses and may request recent lab work (CBC, metabolic panel, lipids) or recommend you see your primary care doctor for thyroid ultrasound if history warrants it.
If you're cleared to proceed, PlexusDx starts you on Compounded Semaglutide Injection at the lowest therapeutic dose (typically 0.25 mg weekly), which is then titrated upward every 4 weeks based on your tolerance and weight loss response. Your dose may go up—your price won't, staying flat at just $149/month across all dose levels. Follow-up consultations track your progress, screen for side effects, and adjust your regimen. If semaglutide isn't right for you, PlexusDx can pivot to alternative GLP-1 or GIP/GLP-1 compounds, or recommend a different pathway altogether.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
I have a history of gallstones but no symptoms now—can I safely use semaglutide?
Semaglutide increases gallbladder contraction and may trigger stones or cholecystitis. Asymptomatic gallstone history isn't an absolute contraindication but requires careful discussion with your PlexusDx provider and possibly ultrasound confirmation that stones won't cause problems. Your provider may recommend cholelithiasis monitoring during treatment.
Does semaglutide work equally well for everyone, or do genetics play a role?
Genetics significantly influence semaglutide response. About 30–40% of patients experience substantial weight loss, while others see modest results. PlexusDx Precision Peptide Genetic Test identifies your GLP-1 and GIP receptor variants, FTO risk score, and MC4R pathway status—allowing your provider to predict your likely response and pivot to tirzepatide or dual therapy if your genetic profile suggests better outcomes with those compounds.
What's the cost to start semaglutide at PlexusDx, and are there hidden fees?
Compounded Semaglutide Injection starts at $149/month flat—no membership fee, no insurance required. PlexusDx serves all 50 states and accepts HSA/FSA funds. The Precision Peptide Genetic Test costs $99 as an optional add-on after your first month, with no surprise charges for dose adjustments or consultations.
Can I take semaglutide if I'm on diabetes medications like metformin?
Metformin alone is compatible with semaglutide, though it may amplify GI side effects like nausea early on. However, if you take insulin or sulfonylureas (glipizide, glyburide), you face hypoglycemia risk and must coordinate dose reductions with your PlexusDx provider. Always disclose your full diabetes regimen before starting.
Is compounded semaglutide from PlexusDx as safe as brand-name Ozempic?
PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies—regulated facilities that follow FDA manufacturing standards for sterile injection preparation. While not brand-name, the active ingredient (semaglutide) is identical. Quality and safety depend on your pharmacy's licensing and your provider's monitoring—both of which PlexusDx prioritizes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Dosage: What is the Equivalent Dose of Tirzepatide to Semaglutide for Effective Weight Management?
Does Ozempic Always Cause Weight Loss? Exploring the Realities